CoreWeave partnered with Leidos to provide AI cloud services for federal agencies.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Leidos Holdings stock has fallen sharply year to date, yet the company still screens as cheap on several valuation checks, which puts the recent sell off at odds with the current pricing signals. Year to date, Leidos Holdings is down 43.8%, which means the market has rapidly reset expectations after a long period of stronger multi year returns. On the one hand, new federal technology wins and AI focused partnerships can support longer term earnings power, while the health IT contract...
Leidos Holdings (NYSE:LDOS) announced a new partnership with The Modern Data Company focused on federal AI and analytics. The collaboration centers on using Modern Data’s DataOS to connect fragmented government data across systems. The move is part of Leidos’ NorthStar 2030 strategy to expand its digital modernization offerings for federal agencies. Leidos Holdings enters this partnership with The Modern Data Company at a time when the stock is trading around $103.07, with a mixed return...
Leidos Holdings Inc. (NYSE:LDOS) is one of the oversold tech stocks to buy now. On June 25, Leidos partnered with The Modern Data Company to help federal agencies unify fragmented data for AI and analytics without requiring extensive system overhauls. By integrating Modern Data’s DataOS into Leidos’ HeadWay Mission OS, the collaboration creates a secure […]
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.21%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.99%. June E-mini S&P futures (ESM26 ) fell -1.19%, and June E-mini Nasdaq futures...
Defense Health Agency plans to replace Leidos Holdings (NYSE:LDOS) as lead systems integrator for the Military Health System electronic health record program. Change affects the company’s role in the multi year MHS GENESIS rollout across U.S. military treatment facilities. Decision introduces uncertainty for Leidos’ health segment and its position in the federal health IT market. Analysts have issued downgrades citing concerns about profit margins and organic growth alongside this contract...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.30%. June E-mini S&P futures (ESM26 ) are down -0.17%, and June E-mini Nasdaq futures...
Investing.com - U.S. stock futures were broadly steady on Wednesday as investors geared up for a key Federal Reserve interest rate decision and monitored reports on the details of a preliminary Middle East peace agreement.
Leidos Holdings (LDOS) just secured a set of awards under the US Department of State’s multi year Evolve contract, tying the stock more closely to a high profile federal IT modernization effort. See our latest analysis for Leidos Holdings. Against this contract win, Leidos’s share price is up 1.95% over the last day and 5.01% over the past week, yet down 9.44% over 30 days and 25.72% over 90 days. The 3 year total shareholder return of 73.27% contrasts with a weaker 1 year total shareholder...
Leidos Holdings (NYSE:LDOS) has been awarded a US$456 million Military OneSource contract. The award covers wide ranging well being services for service members and their families. The contract is structured as a long term federal engagement serving more than 4.7 million eligible individuals. For investors tracking Leidos primarily as a defense technology and government IT contractor, this Military OneSource award puts the managed health and support services side of the business in sharper...